Core Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	526.52	523.85	509.79	489.74	470.25
Revenue Growth (YoY)	0.51%	2.76%	4.09%	4.14%	-3.49%
Cost of Revenue	417.59	420.52	399.96	393.66	367.9
Gross Profit	108.93	103.33	109.83	96.08	102.36
Selling, General & Admin	45.43	38.59	38.89	37.57	43.87
Amortization of Goodwill & Intangibles	-	0.5	0.49	0.69	0.76
Other Operating Expenses	-7.61	-2.32	-1.21	-1.71	-1.32
Operating Expenses	52.47	51.23	53.47	53.03	61.06
Operating Income	56.47	52.1	56.36	43.05	41.3
Interest Expense	-10.57	-12.37	-13.43	-11.57	-9.15
Earnings From Equity Investments	-	0.24	0.39	0.29	0.06
Currency Exchange Gain (Loss)	-	-1.2	-0.18	-0.23	0.23
EBT Excluding Unusual Items	45.9	38.77	43.15	31.55	32.44
Merger & Restructuring Charges	-	-2.1	-1.14	-3.33	-
Gain (Loss) on Sale of Assets	-	1.78	0.2	1.07	1.44
Asset Writedown	-	-0.7	-1.15	-	-
Other Unusual Items	-	-	0.15	-	-
Pretax Income	45.9	46.19	41.21	29.95	36.11
Income Tax Expense	13.37	14.03	4.18	10.3	15.89
Earnings From Continuing Operations	32.53	32.15	37.03	19.66	20.22
Net Income to Company	32.53	32.15	37.03	19.66	20.22
Minority Interest in Earnings	-0.72	-0.75	-0.35	-0.21	-0.49
Net Income	31.8	31.4	36.68	19.45	19.73
Net Income to Common	31.8	31.4	36.68	19.45	19.73
Net Income Growth	1.28%	-14.38%	88.53%	-1.39%	-
Shares Outstanding (Basic)	47	47	47	46	46
Shares Outstanding (Diluted)	47	48	48	47	47
Shares Change (YoY)	-1.38%	0.34%	1.52%	0.26%	4.98%
EPS (Basic)	0.68	0.67	0.79	0.42	0.43
EPS (Diluted)	0.68	0.66	0.77	0.42	0.42
EPS Growth	2.46%	-14.29%	83.40%	-0.04%	-
Free Cash Flow	22.59	43.36	14.21	14.74	23.04
Free Cash Flow Per Share	0.48	0.91	0.30	0.32	0.49
Dividend Per Share	0.040	0.040	0.040	0.040	0.040
Dividend Growth	-	-	-	-	-85.71%
Gross Margin	20.69%	19.72%	21.55%	19.62%	21.77%
Operating Margin	10.72%	9.95%	11.06%	8.79%	8.78%
Profit Margin	6.04%	5.99%	7.19%	3.97%	4.20%
Free Cash Flow Margin	4.29%	8.28%	2.79%	3.01%	4.90%
EBITDA	71.12	67.05	72.15	60.22	59.81
EBITDA Margin	13.51%	12.80%	14.15%	12.29%	12.72%
D&A For EBITDA	14.65	14.95	15.78	17.16	18.52
EBIT	56.47	52.1	56.36	43.05	41.3
EBIT Margin	10.72%	9.95%	11.06%	8.79%	8.78%
Effective Tax Rate	29.13%	30.39%	10.15%	34.37%	44.01%
Revenue as Reported	-	523.85	509.79	489.74	470.25

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q